Richard Fuller

The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.

Oriel Therapeutics, Inc. develops inhaled drug delivery systems for respiratory diseases and diagnostics. It is a respiratory drug delivery and development company serving the pharmaceutical, biotechnology and diagnostic industries in the development and commercialization of innovative pre-metered unit and multi-dose dry powder delivery systems for medicines for asthma and chronic obstructive pulmonary disease. The company was founded by Paul J. Atkins, Timothy M. Crowder, Richard Fuller and Anthony J. Hickey in 2002 and is headquartered in Durham, NC.

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA.